The terms of the Dexcom-Verily agreement changed in November, but Dexcom CEO Kevin Sayer insists they are still on track for a 2020 launch of the jointly developed G7. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. WTWH Media LLC and its licensors.
Surgical Robotics 5.0: Is Automation the Future? Next up is the G7, but the release of Dexcom’s next-generation CGM will be delayed amid the challenges of setting up and running clinical trials amid the pandemic. The company also has more partnerships with different diabetes data platforms than any of its competitors. "While we wait, and sometimes we forget, we have a fantastic product of what we have in G6, and we will continue to refine and make that better," he said. It allows for device packaging for… […], Becton Dickinson (NYSE:BDX) today announced that the Dutch government has ordered 9.2 million of its rapid, point-of-care, SARS-CoV-2 antigen tests for use on the BD Veritor Plus rapid COVID-19 diagnostic testing system. O'Brien had been under the impression that it was a 14-day trial, but Sayer explained that the pivotal trial is not, in fact, just a 14-day study.
Informa Markets, a trading division of Informa PLC. The G5 still used the iPod-style receiver for the first couple of years, until Dexcom launched its new touchscreen receiver with a vertical orientation. Shares of DexCom (NASDAQ:DXCM) were slipping 6.3% lower as of 11:29 a.m. EDT on Friday. Many users simply rely on the G6 smartphone app to see CGM data and get alerts.
MitraClip, Abbott Park, Ill.-based Abbott’s minimally invasive transcatheter mitral valve repair (TMVR) system, was chosen from a field of 17 other nominees, according to a news release.
Digital Health’s Next Frontier: Women’s Health, Mastering Miniaturization: Solving Your Biggest Challenges with the Smallest Parts Possible. Site by Brooks Digital. The company previously said it expected to see a 17% to 20% revenue bump this year. Importantly, FreeStyle Libre 2 will be offered at the same price as the original FreeStyle Libre. Remember that the Dexcom G6 sensor lasts for 10 days but has a transmitter that is re-used for 90 days.
COVID-19 is creating much uncertainty across the medical device industry, both in terms of revenue guidance and in terms of clinical trial timing. The G4 was launched in 2012 and brought with it a new iPod-style receiver device that was much sleeker and more modern-looking than anything else in CGM technology at the time. It also sounds as though the G7 will be in pivotal trials soon. The healthcare stock could remain volatile until more clarity about the G7 launch timing is available. You can turn your smartphone horizontally to see up to 24 hours of data and scroll back accordingly. That means you’re required to carry a smartphone as the bridge between the CGM and smartwatch, so if you go out but leave your iPhone at home, the Apple Watch and G6 won’t communicate with each other. So, these trials are very well orchestrated and scheduled from a logistics perspective.